RXRX

3.50

4.79% 0.16

Dopo l'orario di chiusura: 3.50

Recursion Pharmaceuticals Inc (RXRX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché RXRX Giù? Forum Previsione

Precedente Chiudi:

$3.34

Aprire:

$3.39

Volume 24 ore:

22.83M

Relative Volume:

1.11

Capitalizzazione di mercato:

$1.88B

Reddito:

$66.41M

Utile/perdita netta:

$-559.78M

Rapporto P/E:

-2.9113

EPS:

-1.2022

Flusso di cassa netto:

$-328.09M

1 W Prestazione:

+10.76%

1M Prestazione:

+13.64%

6M Prestazione:

+2.34%

1 anno Prestazione:

-26.78%

Intervallo 1D:

$3.37

$3.6299

Intervallo di 1 settimana:

$2.92

$3.6299

Portata 52W:

$2.77

$7.18

Recursion Pharmaceuticals Inc Stock (RXRX) Company Profile

Nome

Recursion Pharmaceuticals Inc

Settore

Healthcare (1080)

Industria

Biotechnology (604)

Telefono

(385) 269-0203

Indirizzo

41S RIO GRANDE STREET, SALT LAKE CITY

Dipendente

600

Cinguettio

Prossima data di guadagno

2026-08-04

Ultimi documenti SEC

RXRX's Discussions on Twitter

Compare RXRX vs VRTX, REGN, ARGX, MRNA, RVMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
RXRX Recursion Pharmaceuticals Inc	3.50	1.79B	66.41M	-559.78M	-328.09M	-1.2022
VRTX Vertex Pharmaceuticals Inc	548.05	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	834.04	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,039.78	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.13	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	209.46	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Recursion Pharmaceuticals Inc Stock (RXRX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-12-17	Aggiornamento	JP Morgan	Neutral → Overweight
2025-07-03	Ripresa	Morgan Stanley	Equal-Weight
2023-05-22	Iniziato	Morgan Stanley	Equal-Weight
2023-03-16	Iniziato	Needham	Buy
2022-09-16	Iniziato	KeyBanc Capital Markets	Overweight
2022-04-18	Downgrade	BofA Securities	Buy → Neutral
2022-03-04	Downgrade	SVB Leerink	Outperform → Mkt Perform
2021-09-21	Iniziato	Berenberg	Buy
2021-05-11	Iniziato	BofA Securities	Buy
2021-05-11	Iniziato	Goldman	Neutral
2021-05-11	Iniziato	JP Morgan	Neutral
2021-05-11	Iniziato	KeyBanc Capital Markets	Overweight
2021-05-11	Iniziato	SVB Leerink	Outperform

Mostra tutto

Recursion Pharmaceuticals Inc Borsa (RXRX) Ultime notizie

Aug 21, 2026

Recursion Pharmaceuticals Earnings Call Shows Efficient Progress - TipRanks

Aug 21, 2026

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo

Aug 21, 2026

Aug 20, 2026

RXRX Stock Soars Pre-Market On Q4 Beat, Recursion CEO Says Company Has ‘Reached An Inflection Point’ - Stocktwits

Aug 20, 2026

Recursion (RXRX) Range: Ends Down by 4.86% at $3.33 in Latest Trading; Range Check: the Current Price Sits Inside the Supplied Technical Range for the Current SessionRisk Parity Rebalance - vinanet.vn

Aug 20, 2026

Recursion Pharmaceuticals Stock Climbs 13% As AI Drug Pipeline Progress And Spending Cuts Boost Sentiment - TIKR.com

Aug 20, 2026

Recursion, Novavax, Crispr Therapeutics Stocks Slip Premarket After Cancer Therapy RallyRecursion Phar - Benzinga

Aug 20, 2026

Aug 19, 2026

RXRX Stock Steadies As AI Drug Platform Gains Traction And Cash Burn Tightens - StocksToTrade

Aug 19, 2026

Recursion Pharmaceuticals Stock (RXRX) Opinions on Clinical Pipeline and AI Platform Developments - Quiver Quantitative

Aug 19, 2026

Aug 18, 2026

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Hallett David - Moomoo

Aug 18, 2026

Recursion (NASDAQ: RXRX) CEO's 80K shares withheld for RSU taxes - Stock Titan

Aug 18, 2026

Recursion (NASDAQ: RXRX) CSO sees 26K shares withheld for taxes - Stock Titan

Aug 18, 2026